Inicio › Diabetes tipo 1 › Washington
Ensayos clínicos de Diabetes tipo 1 en Washington
20 estudios sobre Diabetes tipo 1 buscan participantes en Washington.
Ciudades en Washington
Texto oficial del estudio (inglés)
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
ReclutandoEstudio observacional
Edades de 8 a 35 · Todos los sexos · Actualizado el 18 sept 2026 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
ReclutandoFase 2
Edades de 18 a 69 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
ReclutandoFase 3
Edades de 1 a 25 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
ReclutandoFase 1/2
Edades de 12 a 35 · Todos los sexos · Actualizado el 11 sept 2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
ReclutandoFase 2
Edades de 4 a 34 · Todos los sexos · Actualizado el 9 sept 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
ReclutandoFase 2
Edades de 8 a 45 · Todos los sexos · Actualizado el 8 sept 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
ReclutandoFase 1/2
Edades de 9 a 20 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
ReclutandoFase 2
Edades de 5 a 40 · Todos los sexos · Actualizado el 24 ago 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
Reclutando
Edades de 18 a 65 · Todos los sexos · Actualizado el 16 jul 2026 · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 jun 2026 · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 abr 2026 · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
Reclutando
Edades de 18 a 65 · Todos los sexos · Actualizado el 9 abr 2026 · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
ReclutandoFase 2
Edades de 18 a 50 · Todos los sexos · Actualizado el 6 abr 2026 · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 24 mar 2026 · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
ReclutandoFase 3
Edades de 18 a 49 · Todos los sexos · Actualizado el 4 mar 2026 · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
Reclutando
Edades de 16 a 19 · Todos los sexos · Actualizado el 30 dic 2025 · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
ReclutandoEstudio observacional
Hasta los 70 · Todos los sexos · Actualizado el 19 dic 2025 · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
Reclutando
Edades de 12 en adelante · Todos los sexos · Actualizado el 16 dic 2025 · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 2 a 45 · Todos los sexos · Actualizado el 1 jul 2025 · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
ReclutandoFase 1
Edades de 12 a 25 · Todos los sexos · Actualizado el 13 jun 2025 · NCT05065372De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.